ES261175A1 - Procedimiento para la preparaciën de un vector farmaceutico - Google Patents

Procedimiento para la preparaciën de un vector farmaceutico

Info

Publication number
ES261175A1
ES261175A1 ES0261175A ES261175A ES261175A1 ES 261175 A1 ES261175 A1 ES 261175A1 ES 0261175 A ES0261175 A ES 0261175A ES 261175 A ES261175 A ES 261175A ES 261175 A1 ES261175 A1 ES 261175A1
Authority
ES
Spain
Prior art keywords
gelatin
glyoxal
copolymer
weight
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0261175A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES261175A1 publication Critical patent/ES261175A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09H—PREPARATION OF GLUE OR GELATINE
    • C09H7/00—Preparation of water-insoluble gelatine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S8/00—Bleaching and dyeing; fluid treatment and chemical modification of textiles and fibers
    • Y10S8/17—Glyoxal and polyaldehyde treatment of textiles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Procedimiento para la preparación de un vector farmacéutico conveniente para administración oral, que comprende polimerizar la gelatina hidrolizada con alrededor de 2.5 a alrededor de 7% por peso de glioxal basado en el peso de la gelatina.
ES0261175A 1959-10-01 1960-09-21 Procedimiento para la preparaciën de un vector farmaceutico Expired ES261175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US843631A US3028308A (en) 1959-10-01 1959-10-01 Dry pharmaceutical vehicle of copolymer of hydrolyzed gelatin and glyoxal, and its production

Publications (1)

Publication Number Publication Date
ES261175A1 true ES261175A1 (es) 1961-04-01

Family

ID=25290563

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0261175A Expired ES261175A1 (es) 1959-10-01 1960-09-21 Procedimiento para la preparaciën de un vector farmaceutico

Country Status (7)

Country Link
US (1) US3028308A (es)
BE (1) BE595413A (es)
CH (1) CH394494A (es)
DE (1) DE1445105A1 (es)
ES (1) ES261175A1 (es)
GB (1) GB948008A (es)
NL (2) NL125158C (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL252064A (es) * 1960-05-27
US3171831A (en) * 1961-02-14 1965-03-02 Schwarz Biores Inc Thiolation of proteins by reaction with homocysteine thiolactone in the presence of tertiary amine
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3239420A (en) * 1962-10-11 1966-03-08 Vitamix Pharmaceuticals Inc Gelatin composition
NL289785A (es) * 1962-11-29
US3329574A (en) * 1965-04-12 1967-07-04 Schwarz Biores Inc Method and material for selective diffusion
US3480435A (en) * 1965-08-19 1969-11-25 Adam T Krol Production of printing plates and the like
US3301692A (en) * 1966-02-14 1967-01-31 Wilson & Co Inc Process of treating proteins and the product thereof
US3489838A (en) * 1967-10-19 1970-01-13 Phillips Petroleum Co Repelling birds
US3666678A (en) * 1968-01-12 1972-05-30 Benjamin Mosier Process of encapsulating basic nitrogen compounds with acid-precursor gelatin
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4389419A (en) * 1980-11-10 1983-06-21 Damon Corporation Vitamin encapsulation
DE3466702D1 (en) * 1983-07-14 1987-11-12 Hitachi Chemical Co Ltd Gelatin spherical gels and production thereof
JPS6021764A (ja) * 1983-07-14 1985-02-04 日立化成工業株式会社 ゼラチン球状粒子の製造法
CA1335748C (en) * 1986-09-25 1995-05-30 Jeffrey Lawrence Finnan Crosslinked gelatins
US5165944A (en) * 1989-04-19 1992-11-24 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5198251A (en) * 1989-04-19 1993-03-30 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5229148A (en) * 1989-04-19 1993-07-20 Wm. Wrigley Jr. Company Method of combining active ingredients with polyvinyl acetates
US5154939A (en) * 1989-04-19 1992-10-13 Wm. Wrigley Jr. Company Use of salt to improve extrusion encapsulation of chewing gum ingredients
US5108762A (en) * 1989-04-19 1992-04-28 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US4978537A (en) * 1989-04-19 1990-12-18 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
AU639645B2 (en) * 1989-10-10 1993-07-29 Wm. Wrigley Jr. Company Gradual release structures made from fiber spinning techniques
US5128155A (en) * 1990-12-20 1992-07-07 Wm. Wrigley Jr. Company Flavor releasing structures for chewing gum
EP1594471B1 (en) * 2003-02-20 2009-03-25 Constant Research & Development Limited Process for manufacturing a dexamethasone-containing formulation for oral administration
US7771528B2 (en) * 2007-08-16 2010-08-10 The United States Of America As Represented By The Secretary Of Agriculture Processing for producing zein articles with limited solubility
EP2707420A4 (en) * 2011-05-13 2014-10-29 Univ Alberta POLYMERS AND PLASTICS FROM ANIMAL PROTEINS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591133A (en) * 1950-05-29 1952-04-01 California Inst Res Found Method of producing gelatin derivative

Also Published As

Publication number Publication date
NL256065A (es)
NL125158C (es)
GB948008A (en) 1964-01-29
BE595413A (fr) 1961-03-27
DE1445105A1 (de) 1969-01-09
US3028308A (en) 1962-04-03
CH394494A (de) 1965-06-30

Similar Documents

Publication Publication Date Title
GB948008A (en) Pharmaceutical vehicle for the release of drugs in the gastrointestinal tract
JP3010562B2 (ja) 徐放性調剤単位
EP0474098B1 (en) Controlled drug release composition
US5223268A (en) Low solubility drug-coated bead compositions
US4002718A (en) Gelatin-encapsulated digoxin solutions and method of preparing the same
CA1040532A (en) Process for producing solid bismuth-containing pharmaceutical compositions
JPH07145052A (ja) 良好な溶解特性を有する医薬組成物
Speck et al. Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB)
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
US3862311A (en) Novel method of enhancing progestational endometrial proliferation with progesterone
EP0488139A1 (en) Pharmaceutical composition comprising calcium polycarbophil
US3018221A (en) Penicillin-sulfonamide tablet
US3891755A (en) Dosage formulation for erythromycin cetyl sulfate
GB934089A (en) Improvements in or relating to sustained release medicaments
FR2081436B1 (es)
US20020172727A1 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
US3224940A (en) Antacid compositions and method of using same
JPH03128380A (ja) Ｎ↑５，ｎ↑１↑０―メチレン―５，６，７，８―テトラヒドロ葉酸の塩およびその製造方法
US3066075A (en) Compositions comprising amphetamine and carboxymethyl cellulose in chemically combined form
US3068264A (en) Tetracycline antibiotic-aluminumphosphoric acid complexes
US3193459A (en) Steroid hemisuccinate compositions and method for extemporaneous administration
CN118384121B (zh) 左炔诺孕酮肠溶片及其制备方法
CN112704671A (zh) 一种阿莫西林克拉维酸钾胶囊及其制备方法
US3025311A (en) Hydrocortisone 21-beta beta-dimethyl glutarate and derivatives thereof
DE2417565A1 (de) Adenosin-5'-carbohydroxamsaeureester